377 related articles for article (PubMed ID: 33149211)
1. Preconditioning the immature lung with enhanced Nrf2 activity protects against oxidant-induced hypoalveolarization in mice.
Tamatam CM; Reddy NM; Potteti HR; Ankireddy A; Noone PM; Yamamoto M; Kensler TW; Reddy SP
Sci Rep; 2020 Nov; 10(1):19034. PubMed ID: 33149211
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of oxidative stress and Keap-1/Nrf2 signaling pathway in bronchopulmonary dysplasia.
Ma D; Gao W; Liu J; Kong D; Zhang Y; Qian M
Medicine (Baltimore); 2020 Jun; 99(26):e20433. PubMed ID: 32590729
[TBL] [Abstract][Full Text] [Related]
3. Effects of hyperoxia exposure on the expression of Nrf2 and heme oxygenase-1 in lung tissues of premature rats.
Chu X; Zhang X; Gong X; Zhou H; Cai C
Mol Cell Probes; 2020 Jun; 51():101529. PubMed ID: 32036037
[TBL] [Abstract][Full Text] [Related]
4. Autophagy inducer activates Nrf2-ARE pathway to attenuate aberrant alveolarization in neonatal rats with bronchopulmonary dysplasia.
Zhao X; Shi Y; Zhang D; Tong X; Sun Y; Xue X; Fu J
Life Sci; 2020 Jul; 252():117662. PubMed ID: 32298739
[TBL] [Abstract][Full Text] [Related]
5. ZJ01, a Small Molecule Inhibitor of the Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction, Reduces Hyperoxic Acute Lung Injury in a Mouse Model.
Wan J; Lin S; Huang X; Li Q; Zeng L; Du S
Med Sci Monit; 2020 May; 26():e920467. PubMed ID: 32437336
[TBL] [Abstract][Full Text] [Related]
6. Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia.
Popova AP; Bentley JK; Cui TX; Richardson MN; Linn MJ; Lei J; Chen Q; Goldsmith AM; Pryhuber GS; Hershenson MB
Am J Physiol Lung Cell Mol Physiol; 2014 Aug; 307(3):L231-9. PubMed ID: 24907056
[TBL] [Abstract][Full Text] [Related]
7. Nrf2‑Keap1‑ARE‑NQO1 signaling attenuates hyperoxia‑induced lung cell injury by inhibiting apoptosis.
Weng B; Zhang X; Chu X; Gong X; Cai C
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495821
[TBL] [Abstract][Full Text] [Related]
8. Neonatal periostin knockout mice are protected from hyperoxia-induced alveolar simplication.
Bozyk PD; Bentley JK; Popova AP; Anyanwu AC; Linn MD; Goldsmith AM; Pryhuber GS; Moore BB; Hershenson MB
PLoS One; 2012; 7(2):e31336. PubMed ID: 22363622
[TBL] [Abstract][Full Text] [Related]
9. Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia.
Chao CM; Yahya F; Moiseenko A; Tiozzo C; Shrestha A; Ahmadvand N; El Agha E; Quantius J; Dilai S; Kheirollahi V; Jones M; Wilhem J; Carraro G; Ehrhardt H; Zimmer KP; Barreto G; Ahlbrecht K; Morty RE; Herold S; Abellar RG; Seeger W; Schermuly R; Zhang JS; Minoo P; Bellusci S
J Pathol; 2017 Jan; 241(1):91-103. PubMed ID: 27770432
[TBL] [Abstract][Full Text] [Related]
10. The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia.
Thomas JM; Sudhadevi T; Basa P; Ha AW; Natarajan V; Harijith A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163176
[TBL] [Abstract][Full Text] [Related]
11. N-acetyl-lysyltyrosylcysteine amide, a novel systems pharmacology agent, reduces bronchopulmonary dysplasia in hyperoxic neonatal rat pups.
Teng RJ; Jing X; Martin DP; Hogg N; Haefke A; Konduri GG; Day BW; Naylor S; Pritchard KA
Free Radic Biol Med; 2021 Apr; 166():73-89. PubMed ID: 33607217
[TBL] [Abstract][Full Text] [Related]
12. Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist.
Royce SG; Nold MF; Bui C; Donovan C; Lam M; Lamanna E; Rudloff I; Bourke JE; Nold-Petry CA
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):858-868. PubMed ID: 27482635
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic stress exacerbates hyperoxia-induced lung injury in a neonatal mouse model of bronchopulmonary dysplasia.
Ratner V; Slinko S; Utkina-Sosunova I; Starkov A; Polin RA; Ten VS
Neonatology; 2009; 95(4):299-305. PubMed ID: 19052476
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole Attenuates Pulmonary Aryl Hydrocarbon Receptor Activation and Potentiates Hyperoxia-Induced Developmental Lung Injury in Newborn Mice.
Shivanna B; Zhang S; Patel A; Jiang W; Wang L; Welty SE; Moorthy B
Toxicol Sci; 2015 Nov; 148(1):276-87. PubMed ID: 26272953
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation.
Blake DJ; Singh A; Kombairaju P; Malhotra D; Mariani TJ; Tuder RM; Gabrielson E; Biswal S
Am J Respir Cell Mol Biol; 2010 May; 42(5):524-36. PubMed ID: 19520915
[TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice.
Cho HY; van Houten B; Wang X; Miller-DeGraff L; Fostel J; Gladwell W; Perrow L; Panduri V; Kobzik L; Yamamoto M; Bell DA; Kleeberger SR
Antioxid Redox Signal; 2012 Oct; 17(8):1066-82. PubMed ID: 22400915
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 protects against airway disorders.
Cho HY; Kleeberger SR
Toxicol Appl Pharmacol; 2010 Apr; 244(1):43-56. PubMed ID: 19646463
[TBL] [Abstract][Full Text] [Related]
18. Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia.
Li Q; Li R; Wall SB; Dunigan K; Ren C; Jilling T; Rogers LK; Tipple TE
Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L736-L742. PubMed ID: 29368550
[TBL] [Abstract][Full Text] [Related]
19. Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA.
Kim JH; Choi YK; Lee KS; Cho DH; Baek YY; Lee DK; Ha KS; Choe J; Won MH; Jeoung D; Lee H; Kwon YG; Kim YM
Free Radic Biol Med; 2012 Aug; 53(3):629-40. PubMed ID: 22609006
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status.
McGrath-Morrow SA; Lauer T; Collaco JM; Lopez A; Malhotra D; Alekseyev YO; Neptune E; Wise R; Biswal S
Cytokine; 2014 Jan; 65(1):4-9. PubMed ID: 24139870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
